Prima Nexus / Events / 2019

Biochemical and Molecular Identification of Bacteria and Fungi Workshop

Prima Nexus supported the Biochemical and Molecular Identification of Bacteria and Fungi Workshop, run by the Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia (UPM), from 29 to 31 October 2019.

· Workshop · Supported by Prima Nexus

Participants in lab coats at the laboratory benches
Participants in the Department of Microbiology laboratory, UPM, October 2019.

About the workshop

Participants spent three days in the laboratory of the Department of Microbiology learning to identify bacteria and fungi, by biochemical tests and by molecular methods.

Prima Nexus's part

Prima Nexus supported the workshop. For Prima Nexus’s research support today, see the research platforms page.

More of our work with UPM.

Read the story: Prima Nexus supported a bacteria and fungi workshop at UPM and three science conferences in 2019.

About Prima Nexus

Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.

MicrobiologyMolecular biologyBiochemistry

Work with us

Planning a workshop, a study or a lab set-up? Talk to us.

We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.